Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-Related Macular Degeneration (TargetAMD) - CNRS - Centre national de la recherche scientifique Access content directly
Journal Articles Human gene therapy. Clinical development Year : 2015

Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-Related Macular Degeneration (TargetAMD)

Dates and versions

hal-03292699 , version 1 (20-07-2021)

Identifiers

Cite

Gabriele Thumann, Maria Perdikomati-Dahmen, Zsuzsanna Izsvak, Zoltan Ivics, Alfredo Garcia Layana, et al.. Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-Related Macular Degeneration (TargetAMD). Human gene therapy. Clinical development, 2015, 26 (2), pp.97-100. ⟨10.1089/humc.2015.2519⟩. ⟨hal-03292699⟩
15 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More